DOCSLIB.ORG

2150 Stimulants and Anorectics Mental Impairment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2150 Stimulants and Anorectics Mental Impairment 2150 Stimulants and Anorectics Mental impairment. References. Bass; B-bombs; Beans; Bennie; Bennies; Benny and the Jets; 1. Poitrenaud J, et al. Almitrine-raubasine and cognitive impair- Bens; Benz; Benzedrine; Benzidrine; Berick; Billy; Billy Whizz; ment in the elderly: results of a 6-month controlled multicenter Biphetamine; Bippies; Black beauties; Black birds; Black bomb- study. Clin Neuropharmacol 1990; 13 (suppl 3): S100–S108. ers; Black cadillacs; Black hollies; Black mollies; Black and 2. Poitrenaud J, et al. Time course of age-associated memory im- white; Blacks; Blue belly; Blue boy; Blue mollies; Bolt; Bombi- H pairment in 8037 patients treated with Duxil for 6 months. Rev do; Bombita; Bombitas; Boostant; Bottles; Brain pills; Brain N Geriatr 1994; 19: 531–8. ticklers; Brownies; Browns; Bumblebees; Candy; Cartwheels; 3. Poitrenaud J, et al. Memory disorders in 8037 elderly patients Chalk; Chicken powder; Chocolate; Christina; Christmas tree; CH with age-associated memory impairment: multicenter trial with Clear rocks; Coast to coast; Coasts to coasts; Colorado Rockies; 3 a 6-month follow-up under almitrine-raubasine. Eur Neurol 1995; 35 (suppl 1): 43–6. Co-pilot; Crank; Crisscross; Croke; Cross tops; Cross-tops; N 4. Allain H, Bentue-Ferrer D. Clinical efficacy of almitrine-rauba- Crossroads; Crystal; Crystal methadrine; Debs; Dex; Dexadrine; sine: an overview. Eur Neurol 1998; 39 (suppl 1): 39–44. Dexedrine; Dexies; Diamonds; Diet Coke; Diet pills; Dolls; Dominoes; Double cross; Drivers; Eve; Eye opener; Eye open- Profile Respiratory system disorders. Respiratory stimulants (such ers; Fast; Fast balls; Fastin; Fives; Fly Boys; Football; Footballs; Amfetaminil is a central stimulant that has been given orally in as almitrine) have a limited and short-term role in acute respira- Forwards; French blue; French blues; Gaggler; Gas; GB’s; the treatment of narcolepsy. tory failure in chronic obstructive pulmonary disease (p.1112). Glass; Go; Go-ee; Goey; Greenies; Halloo-Wach; Hanyak; Head Preparations Almitrine has been reported1-4 to improve ventilation and blood drugs; Head fruit; Hearts; Hi speeds; High speed; Höökipulveri; oxygenation, and to decrease the number of episodes of dysp- Horse heads; Hydro; Iboga; Ice; Inbetweens; Jam; Jam cecil; Jel- Proprietary Preparations (details are given in Part 3) noea and hospital admissions, although others5 have failed to ly baby; Jelly bean; Jelly beans; Johnny go fast; Jolly bean; Jolly Ger.: AN 1†. note benefit. There are also reports6,7 of beneficial effects when beans; Jugs; Khat; L.A.; La Glass; LA ice; LA turnarounds; used with inhaled nitric oxide in patients with severe hypoxae- Leapers; Lid poppers; Lid proppers; Lightning; Lip poppers; Lit- mic acute respiratory distress syndrome (p.1498) as well as in tle bomb; Little Guys; Louee; Louie; Macka; 357 Magnum; 357 patients with hypoxia caused by focal lung lesions.8 However, Magnums; MAO; Marathons; Marching Powder; Meth; Methe- Amiphenazole Hydrochloride (BANM, rINNM) ⊗ drine; Methlies Quik; Mini beans; Mini berries; Minibennie; any modest benefits may be outweighed by the adverse effects, Amiphénazol, Chlorhydrate d’; Amiphenazole Chloride; Ami- which have included peripheral paraesthesia and weight loss,1 Mollies; Monoamine oxidase; Morning shoot; Morning shot; phenazoli Hydrochloridum; Hidrocloruro de amifenazol. 5-Phe- and headache, urticaria, breathlessness, diarrhoea, chest pain, Nineteen; Nitro; Nugget; Oranges; Peaches; Pep; Pep pills; Per- nausea, and vomiting.3 The peripheral neuropathy that some- vitiini; Pink hearts; Pixies; Pollutants; Powder; Proszek; Pulver; nylthiazole-2,4-diamine hydrochloride. Purple hearts; Rhythm; Rippers; Road dope; Rosa; Roses; times occurs during long-term use of almitrine9,10 may be due to Амифеназола Гидрохлорид 11-13 Shight; Shighty; Slammin’; Slamming; Slipvins; Snap; Snow; an underlying feature of the pulmonary disease being treated, Snow pallets; Sparkle plenty; Sparklers; Speckled birds; Speck- C H N S,HCl = 227.7. although some disagree with this.14 9 9 3 led eggs; Speed; Speed ball; Speed balls; Speed cristal; Speed- CAS — 490-55-1 (amiphenazole); 942-31-4 (amiphena- 1. Watanabe S, et al. Long-term effect of almitrine bismesylate in ball; Spivias; Splash; Splivins; Sprinkles; Star; Strawberry short- zole hydrochloride). patients with hypoxemic chronic obstructive pulmonary dis- cake; Sulph; Sulphate; Sulphates; Sweeties; Sweets; Tens; The ease. Am Rev Respir Dis 1989; 140: 1269–73. 2. Daskalopoulou E, et al. Comparison of almitrine bismesylate C; Thrusters; Toffee whizz; Topette; TR-6s; Truck drivers; Tur- and medroxyprogesterone acetate on oxygenation during wake- key; Turnabout; Turnarounds; Tweak; Tweek; Up; Uppers; Up- fulness and sleep in patients with chronic obstructive lung dis- pies; U.S.P.; Wake amine; Wake ups; Water; West Coast turna- ease. Thorax 1990; 45: 666–9. rounds; Wheels; Whiffle dust; Whiffledust; White; White Cross; S 3. Bakran I, et al. Double-blind placebo controlled clinical trial of White Crunch; Whites; Whiz; Whizz; Wire; X; X-mas tree; NH2 almitrine bismesylate in patients with chronic respiratory insuf- Zoomers. ficiency. Eur J Clin Pharmacol 1990; 38: 249–53. 4. Górecka D, et al. Effects of almitrine bismesylate on arterial N blood gases in patients with chronic obstructive pulmonary dis- Amfetamine Sulfate (rINNM) ⊗ H2N ease and moderate hypoxaemia: a multicentre, randomised, Amfetamiinisulfaatti; Amfétamine, sulfate d’; Amfetamine Sul- double-blind, placebo-controlled study. Respiration 2003; 70: (amiphenazole) 275–83. phate (BANM); Amfetamini sulfas; Amfetamino sulfatas; Amfeta- 5. Sans-Torres J, et al. Long-term effects of almitrine bismesylate minsulfat; Amfetamin-sulfát; Amfetamin-szulfát; Amphetamine in COPD patients with chronic hypoxaemia. Respir Med 2003; Profile 97: 599–605. Correction. ibid.; 1243. Sulfate; Amphetamine Sulphate; Amphetamini Sulfas; Phenami- 6. Jolliet P, et al. Additive beneficial effects of the prone position, num; Phenylaminopropanum Racemicum Sulfuricum; Sulfato de Amiphenazole hydrochloride has properties similar to those of nitric oxide, and almitrine bismesylate on gas exchange and ox- anfetamina. (R,S)-α-Methylphenethylamine sulphate. doxapram hydrochloride (p.2155) and has been used intramus- ygen transport in acute respiratory distress syndrome. Crit Care cularly or intravenously as a respiratory stimulant. Med 1997; 25: 786–94. Амфетамина Сульфат Lichenoid reactions have been reported in addition to those reac- 7. Gallart L, et al. The NO Almitrine Study Group. Intravenous (C H N) ,H SO = 368.5. almitrine combined with inhaled nitric oxide for acute respira- 9 13 2 2 4 tions expected from its central activity. tory distress syndrome. Am J Respir Crit Care Med 1998; 158: CAS — 60-13-9. 1770–7. ATC — N06BA01. 8. Payen D, et al. Inhaled nitric oxide, almitrine infusion, or their ATC Vet — QN06BA01. coadministration as a treatment of severe hypoxemic focal lung lesions. Anesthesiology 1998; 89: 1157–65. Pharmacopoeias. In Chin., Eur. (see p.vii), and US. Ammonium Camphocarbonate 9. Chedru F, et al. Peripheral neuropathy during treatment with Ph. Eur. 6.2 (Amfetamine Sulphate). A white or almost white Canfocarbonato de amonio. almitrine. BMJ 1985; 290: 896. powder. Freely soluble in water; slightly soluble in alcohol. Pro- 10. Gherardi R, et al. Peripheral neuropathy in patients treated with tect from light. C11H19NO3 = 213.3. almitrine dimesylate. Lancet 1985; i: 1247–50. CAS — 5972-75-8. 11. Suggett AJ, et al. Almitrine and peripheral neuropathy. Lancet USP 31 (Amphetamine Sulfate). A white odourless crystalline 1985; ii: 830–1. powder. Freely soluble in water; slightly soluble in alcohol; prac- Profile 12. Alani SM, et al. Almitrine and peripheral neuropathy. Lancet tically insoluble in ether. Its solutions are acid to litmus, having a Ammonium camphocarbonate has been used in preparations for 1985; ii: 1251. pH of 5 to 6. 13. Moore N, et al. Peripheral neuropathy in chronic obstructive the treatment of respiratory-tract disorders. lung disease. Lancet 1985; ii: 1311. Incompatibility. Amfetamine sulfate is incompatible with al- Preparations 14. Louarn F, Gherardi R. Almitrine and peripheral neuropathy. kalis and calcium salts. Lancet 1985; ii: 1068. Proprietary Preparations (details are given in Part 3) Preparations Profile Multi-ingredient: Spain: Pulmofasa. Amfetamine is an indirect-acting sympathomimetic with actions Proprietary Preparations (details are given in Part 3) and uses similar to those of its isomer dexamfetamine (p.2153). Belg.: Vectarion†; Braz.: Vectarion; Denm.: Vectarion; Fr.: Vectarion; Irl.: Vectarion; Pol.: Armanor; Port.: Vectarion; Rus.: Armanor (Арманор); Amfetamine, amfetamine sulfate, and amfetamine aspartate are Spain: Vectarion. given orally in doses similar to those of dexamfetamine sulfate. Armodafinil (USAN, rINN) ⊗ Multi-ingredient: Fr.: Duxil†; Hong Kong: Duxaril; Philipp.: Duxaril; The laevo-isomer, levamfetamine was formerly used in a similar Port.: Duxil; Transoxyl†; Singapore: Duxaril; Spain: Duxor†; Thai.: Dux- manner. Amfetamine, being volatile, was formerly given by in- Armodafinilo; Armodafinilum; CEP-10953; CRL-40982. 2-[(R)- aril. halation. (Diphenylmethyl)sulfinyl]acetamide. Breast feeding. Amfetamine is concentrated in breast milk and Армодафинил 1 the American Academy of Pediatrics has stated that it has C15H15NO2S = 273.4. Amfetamine (BAN, rINN) ⊗ caused irritability and poor sleep pattern in breast-feeding infants CAS — 112111-43-0. Amfetamiini; Amfetamin;
Load more

Recommended publications
  • AO-Klasifikácia Faktúr →Zlomeniny
    AO-klasifikácia faktúr →zlomeniny. AOP-syndróm – skr. syndroma adipositas–oligomenorrhoea–parotis. aorta – [g. aorté srdcovnica] srdcovnica. Začína sa z ľavej komory a vystupuje kraniálne aţ do výšky 2. pravého sternokostálneho kĺbu ako aorta ascendens, pokračovaním je oblúk arcus aortae, aorta descendens, aorta thoracia a aorta abdominalis. Aorta ascendens – začína sa v ľavej komore nad polmesiačikovitými chlopňami a skoro celá sa nachádza v perikarde. Je dlhá asi 4 – 5 cm, jej priemer je 22 – 30 mm. Ihneď nad chlop-ňami je následkom spätných nárazov krvi mierne vydutá do tzv. sinus aortae, výraznejšie u starších osôb. Oddiely a. obsahujúce sinus aortae sa nazývajú bulbus aortae. U starších osôb býva následkom nárazov krvi širší aj koncový úsek vzostupnej a. pred jej prechodom do oblúka, tzv. sinus maximus (quartus) aortae. Tu býva u starších osôb a. často rozširená. A. ascendens, ako aj začiatok arcus aortae majú špeciálne vasa vasorum pochádzajúce z vencovitých tepien (aa. cardiaortales). Tento úsek osobitne patogeneticky rizikový. Začiatok aorta ascendens je ešte obalený vo vagina serosa arteriarum, kt. tvorí na ventrálnom obvode a. priečnu krkvu podloţenú subseróznym tukovým väzivom (Concatova-Bacceli tuková krkva). Vnútri vagina arteriarum je aorta ascendens a začiatrok a. pulmonalis spojené tuhým väzivom (vincula aortae Rindfleischi). Výstup aorta ascendens kryje spredu začiatok a. pulmonalis, ventrálne a vpravo je auricula dextra, dorzálne je uloţený r. dexter a. pulmonalis. Kraniálne vpravo od a. je v. cava superior, vľavo kmeň a. pulmonalis. Z ventrálneho a ľavého sinus aortae sa začína a. coronaria cordis dextra et sinistra. Aorta ascendens a arcus aortae Arcus aortae – je dlhý asi 6 cm, začína sa za sternom vo výške úponu 2.
    [Show full text]
  • UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
    UFC PROHIBITED LIST Effective June 1, 2021 THE UFC PROHIBITED LIST UFC PROHIBITED LIST Effective June 1, 2021 PART 1. Except as provided otherwise in PART 2 below, the UFC Prohibited List shall incorporate the most current Prohibited List published by WADA, as well as any WADA Technical Documents establishing decision limits or reporting levels, and, unless otherwise modified by the UFC Prohibited List or the UFC Anti-Doping Policy, Prohibited Substances, Prohibited Methods, Specified or Non-Specified Substances and Specified or Non-Specified Methods shall be as identified as such on the WADA Prohibited List or WADA Technical Documents. PART 2. Notwithstanding the WADA Prohibited List and any otherwise applicable WADA Technical Documents, the following modifications shall be in full force and effect: 1. Decision Concentration Levels. Adverse Analytical Findings reported at a concentration below the following Decision Concentration Levels shall be managed by USADA as Atypical Findings. • Cannabinoids: natural or synthetic delta-9-tetrahydrocannabinol (THC) or Cannabimimetics (e.g., “Spice,” JWH-018, JWH-073, HU-210): any level • Clomiphene: 0.1 ng/mL1 • Dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3): 0.1 ng/mL • Selective Androgen Receptor Modulators (SARMs): 0.1 ng/mL2 • GW-1516 (GW-501516) metabolites: 0.1 ng/mL • Epitrenbolone (Trenbolone metabolite): 0.2 ng/mL 2. SARMs/GW-1516: Adverse Analytical Findings reported at a concentration at or above the applicable Decision Concentration Level but under 1 ng/mL shall be managed by USADA as Specified Substances. 3. Higenamine: Higenamine shall be a Prohibited Substance under the UFC Anti-Doping Policy only In-Competition (and not Out-of- Competition).
    [Show full text]
  • Doping Control of Athletes
    trends in analytical chemistry, vol. 7, no. IO, I988 375 trends Doping control of athletes E. G. de Jong*, I?. A. A. Maes and The definition of the Council of Europe for doping J. M. van Rossum is2: Utrecht, Netherlands ‘The administration to or the use by a healthy indi- vidual in any way of compounds which are not natu- History ral to the organism or the use of physiological com- The origin of the word doping is not certain. It first pounds in abnormal doses or in an abnormal way appeared in the English dictionaries at the end of the with the only purpose to artificially and dishonestly nineteenth century. The first reference to the use of influence the performance of this person during doping by athletes was in 1864 during swimming competition.’ competitions that were held in the canals of Amster- Another possible definition is: dam. The use of what is known as a ‘speedball’, a ‘The use of compounds which are not synthesized mixture of heroine and cocaine, by cyclists was de- by the human body or the use of endogenous com- scribed in 1869. In 1904 the Russian chemist pounds in excessive doses with the aim to improve Bukowski was able to identify some alkaloids in the performance in sport competitions.’ saliva of horses’. A simpler definition is: Australia was the first country to take measures ‘The use of forbidden drugs. ’ against doping in sports in 1962, and England fol- The last definition can only be used when we have lowed with the drugs bill in 1964.
    [Show full text]
  • Southern Africa Pga Tour Npc Anti-Doping Program Guide
    SOUTHERN AFRICA PGA TOUR NPC (Association Incorporated under Section 21) ANTI-DOPING PROGRAM GUIDE 2018 Sunshine Tour Anti-Doping Program Guide 2018 Page 1 Contents Page Section 1 Player Guide to the Anti-Doping Program 3 Section 2 Player Guide to Prohibited Substances 7 Section 3 Sunshine Tour Anti-Doping Program 14 Section 4 Anti-Doping Program Definitions 25 Section 5 Sunshine Tour List of Prohibited Substances and Methods 28 Section 6 Therapeutic Use Exemption Declaration & Application 36 Section 7 Player Resources 36 Sunshine Tour Anti-Doping Program Guide 2018 Page 2 SECTION 1 PLAYER GUIDE TO THE SUNSHINE TOUR ANTI DOPING PROGRAM Who is covered by the Sunshine Tour’s Anti-Doping Program? The anti-doping program (the “Program”) was developed in co-operation with the South African Institute for Drug-Free Sport (“SAIDS”) to protect the integrity that is inherent in the sport of golf and to ensure the health and safety of all players. SAIDS was established as a statutory body by the South African Institute for Drug-Free Sport Act no. 14 of 1997 as the independent National Anti-Doping Organisation for South Africa. The SUNSHINE TOUR recognises the independence and jurisdiction of SAIDS. All SUNSHINE TOUR members and BIG EASY TOUR members are bound by the Program. Additionally, any player who participates in a SUNSHINE TOUR co-sanctioned, sanctioned, approved or coordinated tournament is bound by the Program. What substances and methods are prohibited? The World Anti-Doping Agency (WADA) List of Prohibited Substances and Methods (the “List”), in force at the time, defines what is prohibited and the SUNSHINE TOUR List of Prohibited Substances and Methods is based on the List.
    [Show full text]
  • Systematic Evaluation of 1-Chlorobutane for Liquid-Liquid Extraction of Drugs U
    Systematic evaluation of 1-chlorobutane for liquid-liquid extraction of drugs U. Demme1*, J. Becker2, H. Bussemas3, T. Daldrup4, F. Erdmann5, M. Erkens6, P.X. Iten7, H. Käferstein8, K.J. Lusthof9, H.J. Magerl10, L.v. Meyer11, A. Reiter12, G. Rochholz13, A. Schmoldt14, E. Schneider15, H.W. Schütz13, T. Stimpfl16, F. Tarbah17, J. Teske18, W. Vycudilik16, J.P. Weller18, W. Weinmann19 *On behalf of the “Workgroup Extraction“ of the GTFCh (Society of Toxicological and Forensic Chemistry, Germany) Institutes of Forensic Medicine of 1Jena, 2Mainz, 4Duesseldorf, 5Giessen, 7Zuerich (CH), 8Cologne, 10Wuerzburg, 11Munich, 12Luebeck, 13Kiel, 14Hamburg, 16Vienna (A), 18Hannover, 19Freiburg and 3Praxis Labormedizin Dortmund, 6Clin.-Chem. Central Laboratory, Aachen, 9Nat. For. Inst., Den Haag (NL), 15LKA Baden-Wuerttemberg, Stuttgart 17Dubai Police Dept. Introduction In systematic toxicological analysis (STA), chromatographic Experimental Buffer solutions (pH 9) were obtained by dissolving 10 g methods are widely used for the detection of drugs and other organic toxic substances in Na2HPO4 (VWR) in one liter of distilled water. 1-chlorobutane and methanol (analytical biological materials, such as blood, plasma, urine, hair and tissue samples. In most cases grade) were obtained from VWR International (Darmstadt, Germany). Drugs were the applied analytical methods like gas chromatography-mass spectrometry (GC/MS), purchased as pure compounds or as salts from chemical suppliers (Sigma high performance liquid chromatography with diode-array detection (HPLC/DAD), Deissenhofen/Germany and others) or from the pharmaceutical manufacturers and were HPLC/mass spectrometry (LC/MS), or thin-layer chromatography with remission first dissolved in methanol to achieve a concentration of 1 mg/mL. In some instances the spectroscopy (TLC/UV), require sample preparation by extraction prior to analysis.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Anti-Doping Manual Revised Dec. 2018
    PGA TOUR Anti-Doping Program Manual REVISED DECEMBER 2018 Table of Contents How To Use This Manual .......................................................................................................................................................2 SECTION 1: Player Guide To Anti-Doping ...........................................................................................................................3 Who is covered by the Anti-Doping Program .........................................................................................................3 What substances and methods are banned ..........................................................................................................3 Am I liable for a prohibited substance in my body even if I did not intend to take the substance ........................3 What should players know about nutritional and health products ...................................................................3 Are there supplements that have been tested/certified as free from banned substances ........................3 What about medical treatment.................................................................................................................................4 What medications are permitted .............................................................................................................................4 Who conducts the testing and who will be tested ................................................................................................4 What are the steps in
    [Show full text]
  • Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)
    British Journal of Pharmacology (2008) 154, 606–622 & 2008 Nature Publishing Group All rights reserved 0007– 1188/08 $30.00 www.brjpharmacol.org REVIEW Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) JR Docherty Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland This review examines the pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Stimulants that increase alertness/reduce fatigue or activate the cardiovascular system can include drugs like ephedrine available in many over- the-counter medicines. Others such as amphetamines, cocaine and hallucinogenic drugs, available on prescription or illegally, can modify mood. A total of 62 stimulants (61 chemical entities) are listed in the WADA List, prohibited in competition. Athletes may have stimulants in their body for one of three main reasons: inadvertent consumption in a propriety medicine; deliberate consumption for misuse as a recreational drug and deliberate consumption to enhance performance. The majority of stimulants on the list act on the monoaminergic systems: adrenergic (sympathetic, transmitter noradrenaline), dopaminergic (transmitter dopamine) and serotonergic (transmitter serotonin, 5-HT). Sympathomimetic describes agents, which mimic sympathetic responses, and dopaminomimetic and serotoninomimetic can be used to describe actions on the dopamine and serotonin systems. However, many agents act to mimic more than one of these monoamines, so that a collective term of monoaminomimetic may be useful. Monoaminomimietic actions of stimulants can include blockade of re-uptake of neurotransmitter, indirect release of neurotransmitter, direct activation of monoaminergic receptors. Many of the stimulants are amphetamines or amphetamine derivatives, including agents with abuse potential as recreational drugs.
    [Show full text]
  • 2019 Prohibited List
    THE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2019 The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2019 SUBSTANCES & METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL BE CONSIDERED AS “SPECIFIED SUBSTANCES” EXCEPT SUBSTANCES IN CLASSES S1, S2, S4.4, S4.5, S6.A, AND PROHIBITED METHODS M1, M2 AND M3. PROHIBITED SUBSTANCES NON-APPROVED SUBSTANCES Mestanolone; S0 Mesterolone; Any pharmacological substance which is not Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien- addressed by any of the subsequent sections of the 3-one); List and with no current approval by any governmental Metenolone; regulatory health authority for human therapeutic use Methandriol; (e.g. drugs under pre-clinical or clinical development Methasterone (17β-hydroxy-2α,17α-dimethyl-5α- or discontinued, designer drugs, substances approved androstan-3-one); only for veterinary use) is prohibited at all times. Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien- 3-one); ANABOLIC AGENTS Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α- S1 androst-1-en-3-one); Anabolic agents are prohibited. Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en- 3-one); 1. ANABOLIC ANDROGENIC STEROIDS (AAS) Methyltestosterone; a. Exogenous*
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]
  • 2021 Equine Prohibited Substances List
    2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s). Prohibited Substances that are identified as Specified Substances in the List below should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by Horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance. LISTED AS SUBSTANCE ACTIVITY BANNED 1-androsterone Anabolic BANNED 3β-Hydroxy-5α-androstan-17-one Anabolic BANNED 4-chlorometatandienone Anabolic BANNED 5α-Androst-2-ene-17one Anabolic BANNED 5α-Androstane-3α, 17α-diol Anabolic BANNED 5α-Androstane-3α, 17β-diol Anabolic BANNED 5α-Androstane-3β, 17α-diol Anabolic BANNED 5α-Androstane-3β, 17β-diol Anabolic BANNED 5β-Androstane-3α, 17β-diol Anabolic BANNED 7α-Hydroxy-DHEA Anabolic BANNED 7β-Hydroxy-DHEA Anabolic BANNED 7-Keto-DHEA Anabolic CONTROLLED 17-Alpha-Hydroxy Progesterone Hormone FEMALES BANNED 17-Alpha-Hydroxy Progesterone Anabolic MALES BANNED 19-Norandrosterone Anabolic BANNED 19-Noretiocholanolone Anabolic BANNED 20-Hydroxyecdysone Anabolic BANNED Δ1-Testosterone Anabolic BANNED Acebutolol Beta blocker BANNED Acefylline Bronchodilator BANNED Acemetacin Non-steroidal anti-inflammatory drug BANNED Acenocoumarol Anticoagulant CONTROLLED Acepromazine Sedative BANNED Acetanilid Analgesic/antipyretic CONTROLLED Acetazolamide Carbonic Anhydrase Inhibitor BANNED Acetohexamide Pancreatic stimulant CONTROLLED Acetominophen (Paracetamol) Analgesic BANNED Acetophenazine Antipsychotic BANNED Acetophenetidin (Phenacetin) Analgesic BANNED Acetylmorphine Narcotic BANNED Adinazolam Anxiolytic BANNED Adiphenine Antispasmodic BANNED Adrafinil Stimulant 1 December 2020, Lausanne, Switzerland 2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s).
    [Show full text]